Literature DB >> 21196224

Antigen presentation in EAE: role of microglia, macrophages and dendritic cells.

Beatriz Almolda1, Berta Gonzalez, Bernardo Castellano.   

Abstract

Experimental autoimmune encephalomyelitis (EAE), a well-established model of multiple sclerosis, is characterised by microglial activation and lymphocytic infiltration. Lymphocytic activation through the antigen presentation process involves three main signals, the first provided by the engagement of major histocompatibility complex molecules (MHC) with the receptor of T-cells (TCR), the second by the binding of co-stimulatory molecules and the third by the secretion or expression of T-cell polarising molecules in specific populations of antigen presenting cells (APC). Microglial cells are considered to be the main APC population in the central nervous system (CNS). Specifically in EAE an increase in MHCs, co-stimulatory molecules and different T-cell polarising factors have been reported in microglia. However, a growing number of evidences suggest that dendritic cells (DCs), the main APC in the peripheral immune system, may also participate in the regulation of T-cell responses within the CNS. In this review we summarize the principal knowledge regarding microglial/macrophage function in EAE and their role in T-cell modulation, as well as the participation of DCs in the immune response associated to this disease.

Entities:  

Mesh:

Year:  2011        PMID: 21196224     DOI: 10.2741/3781

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  51 in total

1.  Human endometrial-derived mesenchymal stem cells suppress inflammation in the central nervous system of EAE mice.

Authors:  J P S Peron; T Jazedje; W N Brandão; P M Perin; M Maluf; L P Evangelista; S Halpern; M G Nisenbaum; C E Czeresnia; M Zatz; N O S Câmara; L V Rizzo
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 2.  Innate immunity in the central nervous system.

Authors:  Richard M Ransohoff; Melissa A Brown
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 3.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

4.  Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.

Authors:  Chan Chen; Yan-hua Li; Qiong Zhang; Jie-zhong Yu; Yong-fei Zhao; Cun-gen Ma; Bao-guo Xiao
Journal:  Acta Pharmacol Sin       Date:  2014-09-29       Impact factor: 6.150

Review 5.  The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration.

Authors:  Jared T Hinkle; Valina L Dawson; Ted M Dawson
Journal:  Mov Disord       Date:  2019-05-28       Impact factor: 10.338

6.  Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis.

Authors:  Andrea Rottlaender; Hannah Villwock; Klaus Addicks; Stefanie Kuerten
Journal:  Immunology       Date:  2011-05-13       Impact factor: 7.397

Review 7.  Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.

Authors:  Rory D Spence; Rhonda R Voskuhl
Journal:  Front Neuroendocrinol       Date:  2011-12-24       Impact factor: 8.606

Review 8.  End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology.

Authors:  Mirjana Dimitrijevic; Stanislava Stanojevic; Natasa Kustrimovic; Gordana Leposavic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

9.  Diazoxide attenuates autoimmune encephalomyelitis and modulates lymphocyte proliferation and dendritic cell functionality.

Authors:  N Virgili; P Mancera; C Chanvillard; A Wegner; B Wappenhans; M J Rodríguez; C Infante-Duarte; J F Espinosa-Parrilla; M Pugliese
Journal:  J Neuroimmune Pharmacol       Date:  2014-06-18       Impact factor: 4.147

10.  Tubby regulates microglial phagocytosis through MerTK.

Authors:  Nora B Caberoy; Gabriela Alvarado; Wei Li
Journal:  J Neuroimmunol       Date:  2012-08-09       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.